Siren, L.L.C. Q3 2024 Filing
Filed November 13, 2024
Portfolio Value
$2.0T
Holdings
110
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (110 positions)
| Stock | Value |
|---|---|
KYMRKymera Therapeutics Inc | $140.6B |
ONCBeigene Ltd | $126.5B |
SRRKScholar Rock Holding Corp | $90.2B |
BCAXBicara Therapeutics Inc | $78.3B |
ARGXArgenx SE | $77.9B |
CRNXCrinetics Pharmaceuticals Inc | $66.9B |
RNAAvidity Biosciences Inc | $66.2B |
APLSApellis Pharmaceuticals Inc | $62.5B |
LXRXLexicon Pharmaceuticals Inc | $61.1B |
1K0IGM Biosciences Inc | $55.1B |
CNTACentessa Pharmaceuticals PLC | $52.1B |
ASNDAscendis Pharma A/S | $51.9B |
SLNSilence Therapeutics PLC | $51.5B |
ARWRArrowhead Pharmaceuticals Inc | $47.6B |
WVEWAVE Life Sciences Ltd | $46.9B |
SWTXSpringWorks Therapeutics Inc | $44.1B |
DYNDyne Therapeutics Inc | $40.8B |
VERAVera Therapeutics Inc | $37.0B |
NMRANeumora Therapeutics Inc | $34.4B |
PCVXVaxcyte Inc | $34.3B |
RVMDRevolution Medicines Inc | $34.2B |
MRUSMerus NV | $34.1B |
TBLATaboola.com Ltd | $33.5B |
—Longboard Pharmaceuticals Inc | $30.1B |
XENEXenon Pharmaceuticals Inc | $29.3B |
CYTKCytokinetics Inc | $27.8B |
KURAKura Oncology Inc | $26.2B |
RCUSArcus Biosciences Inc | $24.6B |
DNLIDenali Therapeutics Inc | $24.3B |
ERASErasca Inc | $24.2B |
CGEMCullinan Therapeutics Inc | $20.3B |
TNGXTango Therapeutics Inc | $20.1B |
SLDBSolid Biosciences Inc | $19.2B |
PRTAProthena Corporation PLC | $18.4B |
NAMSNewAmsterdam Pharma Company NV | $15.3B |
BHVNBiohaven Ltd | $14.2B |
KRROKorro Bio Inc | $14.0B |
APLTApplied Therapeutics Inc | $13.9B |
GOSSGossamer Bio Inc | $13.3B |
TILInstil Bio Inc | $13.0B |
EWTXEdgewise Therapeutics Inc | $10.8B |
IOVAIovance Biotherapeutics Inc | $10.4B |
ORICOric Pharmaceuticals Inc | $10.3B |
ISIIonis Pharmaceuticals Inc | $10.0B |
TSHATaysha Gene Therapies Inc | $9.8B |
MSFTMicrosoft Corp | $9.5B |
RNACCartesian Therapeutics Inc | $9.2B |
SLRNACELYRIN Inc | $8.5B |
PHATPhathom Pharmaceuticals Inc | $8.3B |
SEERSeer Inc | $7.9B |
RAPPRapport Therapeutics Inc | $7.9B |
NGNENeurogene Inc | $7.4B |
GBIOGBXGeneration Bio Co | $7.4B |
IHSIHS Holding Limited | $7.0B |
CRWDCrowdStrike Holdings Inc | $7.0B |
VIGLVigil Neuroscience Inc | $6.8B |
FHTXFoghorn Therapeutics Inc. | $6.7B |
NOWServiceNow Inc | $6.7B |
AMZNAmazon.com Inc | $6.5B |
BIOABIOAGE Labs Inc | $6.2B |
NVDANVIDIA Corp | $5.9B |
SYRSSyros Pharmaceuticals Inc | $5.6B |
NVCRNovocure Ltd | $5.5B |
LXEOLexeo Therapeutics Inc | $5.5B |
PDDPDD Holdings Inc | $5.4B |
—Allovir Inc | $5.3B |
BDTXBlack Diamond Therapeutics Inc | $4.6B |
ANROAlto Neuroscience Inc | $4.5B |
DTDynatrace Inc | $4.4B |
IONQIONQ Inc | $4.4B |
TSMTaiwan Semiconductor Manufacturing Co Ltd | $4.3B |
AGENAgenus Inc | $4.2B |
DDOGDatadog Inc | $3.8B |
ADCTADC Therapeutics SA | $3.7B |
SESea Ltd | $3.5B |
OVIDOvid Therapeutics Inc | $3.4B |
PYPLPayPal Holdings Inc | $3.2B |
RGNXRegenxbio Inc | $3.0B |
N1UANew Oriental Education & Technology Group Inc | $2.9B |
QCOMQualcomm Inc | $2.6B |
HOOKHOOKIPA Pharma Inc | $2.4B |
TRMLTourmaline Bio Inc | $2.4B |
SGMTSagimet Biosciences Inc | $2.0B |
PCORProcore Technologies Inc | $2.0B |
BEKEKe Holdings Inc | $2.0B |
VVisa Inc | $1.9B |
2JQGritstone bio Inc | $1.9B |
GOOGLAlphabet Inc | $1.8B |
OXYOccidental Petroleum Corp | $1.8B |
FROGJfrog Ltd | $1.8B |
—Omega Therapeutics Inc | $1.6B |
NTRANatera Inc | $1.6B |
PANWPalo Alto Networks Inc | $1.5B |
ESTCElastic NV | $997.9M |
INTCIntel Corp | $938.4M |
METAMeta Platforms Inc | $858.7M |
KRON1USDKronos Bio Inc | $842.9M |
TERNTerns Pharmaceuticals Inc | $834.0M |
RBRKRubrik Inc | $803.8M |
698Achilles Therapeutics PLC | $770.5M |
Page 1 of 2Next